Literature DB >> 2360402

Cardiovascular reflexes in Parkinson's disease: long-term effects of levodopa treatment on de novo patients.

M Camerlingo1, B Ferraro, G C Gazzaniga, L Casto, B M Cesana, A Mamoli.   

Abstract

Twelve parkinsonian patients (6 men and 6 women), mean age 60.5 years, range 47-72, were examined with autonomic test when de novo and after 2 years of continuous levodopa treatment. They were all free from any disease interfering with autonomic examination. When de novo they had a significant decrease of heart rate response to deep breathing and to laying to standing tests if compared with an age- and sex-matched control group (15.6 +/- 8.8 vs. 28.6 +/- 12.1, P less than 0.01 and 7.0 +/- 7 vs. 14.2 +/- 5, P less than 0.01). After 2 years of levodopa treatment they had a non-significant decrease of heart rate response to deep breathing test (21.8 +/- 10.6, P N.S.) and a still significant decrease of heart rate response to laying to standing test, but at a lesser level (7.7 +/- 7.0, P less than 0.05). Furthermore, they showed a significant decrease of the systolic and MAP orthostatic pressure to tilting table (-9.2 +/- 12.0 vs. +4.9 +/- 8.9 and -4.5 +/- 8.4 vs. +4.7 +/- 5.1, both P less than 0.01) probably due to medication. The other tests were never significant. We hazard as possible explanation an action of levodopa on dopaminergic neurons in the nucleus dorsalis of vagus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360402     DOI: 10.1111/j.1600-0404.1990.tb01568.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  13 in total

1.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  Sympathetic vasoconstrictor reflexes in Parkinson's disease with autonomic dysfunction.

Authors:  E B Andersen; F Boesen
Journal:  Clin Auton Res       Date:  1997-02       Impact factor: 4.435

3.  Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features.

Authors:  Margaret K Y Mak; Marco Y C Pang
Journal:  J Neurol       Date:  2010-05-07       Impact factor: 4.849

4.  Autonomic Nervous System Dysfunction in Parkinson's Disease.

Authors:  Theresa A. Zesiewicz; Matthew J. Baker; Mervat Wahba; Robert A. Hauser
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

5.  The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses.

Authors:  A Mesec; S Sega; T Kiauta
Journal:  Clin Auton Res       Date:  1993-10       Impact factor: 4.435

Review 6.  Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.

Authors:  J M Senard; C Brefel-Courbon; O Rascol; J L Montastruc
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Prevalence of orthostatic hypotension in Parkinson's disease.

Authors:  J M Senard; S Raï; M Lapeyre-Mestre; C Brefel; O Rascol; A Rascol; J L Montastruc
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

8.  Age and duration related changes in muscle sympathetic nerve activity in Parkinson's disease.

Authors:  K Shindo; H Watanabe; H Tanaka; K Ohashi; T Nagasaka; S Tsunoda; Z Shiozawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

9.  Cardiovascular reflexes in Parkinson disease.

Authors:  R Martín; R Manzanares; J M Moltó; T Canet; C Ruiz; J Matías-Guiu
Journal:  Ital J Neurol Sci       Date:  1993-09

10.  The management of orthostatic hypotension in Parkinson's disease.

Authors:  Alvaro Sánchez-Ferro; Julián Benito-León; Juan Carlos Gómez-Esteban
Journal:  Front Neurol       Date:  2013-06-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.